Variable | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
OR | 95% CI | p-value | Adjusted OR | 95% CI | p-value | ||
Age, per 10 years older | 1.02 | 0.52-2.03 | 0.945 | 1.23 | 0.53-2.87 | 0.624 | |
Female | 0.78 | 0.21-2.89 | 0.707 | 1.36 | 0.17-11.1 | 0.775 | |
Body mass index, per 5 kg/m2 increase | 0.62 | 0.20-1.89 | 0.403 | 0.59 | 0.18-2.00 | 0.398 | |
Non-white ethnicity | 1.70 | 0.50-5.83 | 0.397 | - | - | - | |
Risk | Men who have sex with men | 1* | - | - | - | - | - |
Heterosexual | 1.04 | 0.22-4.91 | 0.960 | - | - | - | |
Intravenous drug use | 1.40 | 0.23-8.46 | 0.714 | - | - | - | |
Prior AIDS-defining condition | 0.65 | 0.16-2.70 | 0.553 | - | - | - | |
Antiretroviral treatment | 0.31 | 0.26-1.21 | 0.120 | 0.87 | 0.14-5.65 | 0.888 | |
CD4 cell count, per 50 cells/μL increase | 1.01 | 0.85-1.20 | 0.904 | - | - | - | |
CD4 cell count ≥200 versus < 200 cells/μL | 2.55 | 0.72-8.96 | 0.146 | 1.41 | 0.27-7.39 | 0.682 | |
CD8 cell count, per 50 cells/μL increase | 0.97 | 0.93-1.02 | 0.292 | - | - | - | |
Positive TST (≥ 5 mm) | 1.63 | 0.40-6.63 | 0.493 | - | - | - | |
Extrapulmonary versus pulmonary TB | 2.13 | 0.61-7.41 | 0.237 | - | - | - | |
Time between cells freezing and IGRA performance, per month | 0.99 | 0.98-1.01 | 0.453 | - | - | - |